Recent Expansions PerkinElmer Genomics has been actively expanding its product portfolio with the introduction of new imaging systems and whole genome sequencing offerings, presenting opportunities to engage with customers looking for cutting-edge genetic testing solutions.

Strategic Partnerships Partnerships with companies like Agios Pharmaceuticals and Helix have enabled PerkinElmer Genomics to offer innovative genetic testing programs, creating avenues for collaborative sales initiatives and reaching new customer segments.

Focus on Rare Diseases With a focus on rare diseases and hereditary conditions, PerkinElmer Genomics provides specialized genetic and genomic testing services that cater to niche markets, offering a unique selling proposition to healthcare providers and institutions.

Market Trend Alignment Aligning with market trends towards personalized healthcare and proactive health management, PerkinElmer Genomics' exome sequencing-based tests empower consumers to make informed health decisions, tapping into the growing demand for personalized genetic services.

Strong Healthcare Network Collaborations with healthcare institutions like Women & Infants Hospital of Rhode Island demonstrate PerkinElmer Genomics' engagement with the healthcare community, presenting opportunities for relationship-based sales strategies and expansion into clinical settings.